Cognitive function is known to change during normal aging and in age-related disease such as Alzheimer’s disease. Although the exact cause for age-related cognitive decline is not clear, recent studies … Continue Reading Researchers combat memory loss by enhancing brain function in animal model.
In Alzheimer’s, the brain begins to change years before symptoms emerge. Detecting Alzheimer’s antibodies at the preclinical stage would give patients an opportunity to work with their physician to make … Continue Reading Researchers nearing a blood test for Alzheimer’s disease.
Worldwide, more than 20% of persons over the age of 85 suffer from Alzheimer’s disease. Deposits of beta-amyloid (Aβ) peptide represent an important target for research into Alzheimer’s disease. These … Continue Reading Researchers take a step towards utilising the brain’s microglia to fight Alzheimer’s disease.
Air pollution is a serious public health issue and exposures to concentrations of air pollutants at or above the current standards has been linked to neuroinflammation and neurodegeneration. In the … Continue Reading Study shows that air pollution has detrimental impact on Alzheimer’s risk gene.
The need for a new approach to treat Alzheimer’s is an urgent priority for governments across the globe. It is the most common age-related dementia, and the number of people … Continue Reading Gamechanging human study identifies 3 distinct subtypes of Alzheimer’s disease.
Alzheimer’s is the most common form of dementia globally and affects up to 40,000 people in Ireland today. It is the fourth leading cause of death in individuals over the … Continue Reading Researchers have discovered clearance of Alzheimer’s protein across the blood-brain barrier.
More than five million Americans are living with Alzheimer’s disease (AD). Of them, 400,000 also have Down syndrome. People with Down syndrome (DS) represent the world’s largest population of predetermined … Continue Reading Study validates beta amyloid as cause of dementia in both Alzheimer’s and Down syndrome.
It has been known for some years that Alzheimer’s disease is characterised by two types of lesions, amyloid plaques and degenerated tau protein. The amyloid component and altered cholesterol metabolism … Continue Reading Study shows link between the tau component of Alzheimer’s and cholesterol.
Alzheimer’s is the most common form of dementia, causing problems with memory, thinking and behaviour. Symptoms usually develop slowly and get worse over time as it is a progressive disease; … Continue Reading Largest ever human trial shows resveratrol impacts Alzheimer’s biomarker.
Today, more than 5.1 million Americans live with Alzheimer’s disease, a devastating type of dementia that plagues memory and thinking. That number is expected to triple in the coming decades. … Continue Reading Work begins on turning an ApoE4 Alzheimer’s brain into an ApoE2 Alzheimer’s brain.
Tauopathies are neurodegenerative diseases that are signified by the presence of irregular tangle-like clumps of the protein tau that appear in the brain and accumulate during as the disease progresses. … Continue Reading Study identifies a previously unknown mechanism of neurofibrillary tangle formation.
Over 47.5 million people worldwide have Alzheimer’s disease or some other type of dementia, according to the World Health Organization. Despite decades of research, the only medications currently available treat … Continue Reading Fat droplets identified in brains of Alzheimer’s patients for the first time.
Normal kidney function is crucial for regulation of total blood volume and vascular tone. Chronic kidney disease is the reduced ability of the kidney to carry out these functions in … Continue Reading Human study shows kidney impairment boosts risk of stroke and dementia.
Researchers identify protein in the brain which inhibits key enzyme implicated in Alzheimer’s disease.
The need for a new approach to treatment of Alzheimer’s disease is urgent. Alzheimer’s is the most common age-related dementia and the number of cases in the United States is … Continue Reading Researchers identify protein in the brain which inhibits key enzyme implicated in Alzheimer’s disease.
It is well-known that insulin resistance is common in people who are obese, pre-diabetic or have Type 2 diabetes. The fact that obesity increases the risk of cardiovascular disease and … Continue Reading Researchers image the effect of insulin resistance in the brain, link to Alzheimer’s disease.
Currently there is no effective treatments for Alzheimer’s disease, so the focus is on prevention. In the future, medical teams may be able to provide patients with useful and actionable … Continue Reading Cardiovascular risk factors linked to Alzheimer’s disease in human study.